TY  - GEN
AU  - Ingold Heppner,Barbara
AU  - Untch,Michael
AU  - Denkert,Carsten
AU  - Pfitzner,Berit M
AU  - Lederer,Bianca
AU  - Schmitt,Wolfgang
AU  - Eidtmann,Holger
AU  - Fasching,Peter A
AU  - Tesch,Hans
AU  - Solbach,Christine
AU  - Rezai,Mahdi
AU  - Zahm,Dirk M
AU  - Holms,Frank
AU  - Glados,Manfred
AU  - Krabisch,Petra
AU  - Heck,Esther
AU  - Ober,Angelika
AU  - Lorenz,Petra
AU  - Diebold,Kurt
AU  - Habeck,Jörg-Olaf
AU  - Loibl,Sibylle
TI  - Tumor-Infiltrating Lymphocytes: A Predictive and Prognostic Biomarker in Neoadjuvant-Treated HER2-Positive Breast Cancer
SN  - 1557-3265
PY  - 2018///0116
KW  - Biomarkers, Tumor
KW  - metabolism
KW  - Disease-Free Survival
KW  - Female
KW  - Humans
KW  - Lapatinib
KW  - Lymphocytes
KW  - drug effects
KW  - Lymphocytes, Tumor-Infiltrating
KW  - Middle Aged
KW  - Neoadjuvant Therapy
KW  - methods
KW  - Prognosis
KW  - Prospective Studies
KW  - Quinazolines
KW  - therapeutic use
KW  - Receptor, ErbB-2
KW  - Trastuzumab
KW  - Triple Negative Breast Neoplasms
N1  - Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial
UR  - https://doi.org/10.1158/1078-0432.CCR-15-2338
ER  -